Brief: Strides Pharma Science Got USFDA Approval For Levetiracetam Oral Solution
21/11/2023 05:32
Nov 21 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* STRIDES RECEIVES USFDA APPROVAL FOR LEVETIRACETAM ORAL
SOLUTION
Source text for Eikon: ID:nNSEhvMXW
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees